Correlation between dysthyroidism and efficacy in patients treated with anti PD-1 or anti PDL-1 agents. This is an ASCO Meeting Abstract from the 2017 ASCO-SITC Clinical Immuno-Oncology Symposium.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results